PROK Class A ProKidney Corp. - Class A Ordinary Shares
NASDAQ · Biotechnology · View on SEC EDGAR ↗ close Oct 2, 2026 10-K/10-Q Aug 10, 2026
$1.72
· of 52w range
· above low
· to high
$1.3052w low
$3.4852w high
Revenue
$893.0K
your badges
52W Range
$1–$3
Analyst Rating
STRONG BUY
Price Target
$6
P/E
·
ROE
6.9%
Net Profit Margin
-10288.4%
Your badge strip is empty — pin a metric anywhere on this page.
PROK Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
Price
$1.72
Revenue
$893.0K
ROE
6.9%
52W Range
$1–$3
PROK Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
range
bars
Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.
10-Year Performance Revenue, net income, margins and EPS trends
Revenue$893.0K2022-12-31 → 2025-12-31
EPS·2022-12-31 → 2022-12-31
Free Cash Flow$-135M2023-12-31 → 2025-12-31
Net margin-10288.4%2024-12-31 → 2025-12-31
Valuation & Ratios
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
No data for this ratio group yet
Not enough fundamentals data to compute this ratio group yet.
Profitability Gross, operating and net margins; ROE, ROA, ROIC
| Metric | 5Y trend | PROK | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Operating Margin (TTM) | -21664.5% | · | -1576.4% | Weak | |
| EBITDA Margin (TTM) | -20827.6% | · | -1576.4% | Weak | |
| Pretax Margin (TTM) | -20388.4% | · | -2047.6% | Weak | |
| Net Profit Margin (TTM) | -10288.4% | · | -1483.7% | Weak | |
| ROA | -17.8%5Y avg ≈-10.3% | ≈-10.3% | -39.6% | Top tier | |
| ROE | 6.9%5Y avg ≈-53.3% | ≈-53.3% | -59.9% | Top tier | |
| ROIC | 16.4%5Y avg ≈16.4% | ≈16.4% | -33.2% | Top tier |
Financial Health Debt, liquidity, solvency — balance sheet strength
| Metric | 5Y trend | PROK | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Current Ratio (MRQ) | 8.45Y avg ≈8.9 | ≈8.9 | 11.6 | Low liquidity | |
| Quick Ratio | 3.55Y avg ≈2.2 | ≈2.2 | 2.2 | Strong liquidity | |
| Interest Coverage | -41251.85Y avg ≈-24762.3 | ≈-24762.3 | · | · |
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
| Metric | 5Y trend | PROK | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Revenue YoY | 1075.0% | · | · | · |
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
| Metric | 5Y trend | PROK | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Asset Turnover | 0.0 | · | 0.0 | Weak | |
| Revenue / Employee | ≈$3.9K | · | · | · |
value · ≈ 5Y avg · industry median · verdict relative to median
Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date
Avg Surprise
1.8%
Next Report
Nov 09, 2026
| Period | Report | EPS Actual | EPS Est | Surprise |
|---|---|---|---|---|
| June 30, 2026 | $-0.15 | $-0.14 | -4.5% | |
| March 31, 2026 | May 15, 2026 | $-0.14 | $-0.14 | 0.57% |
| Dec. 31, 2025 | $-0.14 | $-0.12 | -12.9% | |
| Sept. 30, 2025 | $-0.12 | $-0.13 | 10.8% | |
| June 30, 2025 | $-0.13 | $-0.15 | 11.5% | |
| March 31, 2025 | $-0.13 | $-0.16 | 19.1% | |
| Dec. 31, 2024 | $-0.17 | $-0.15 | -12.2% |
Full Fundamentals All metrics by year — income statement, balance sheet, cash flow
Income Statement
| Metric | Trend | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | $893.0K | $76.0K | $0 | $0 | |
| R&D Expense | $114M | $128M | $107M | $82M | |
| SG&A Expense | $52M | $56M | $45M | $71M | |
| Operating Expenses | $166M | $184M | $152M | $153M | |
| Operating Income | $-165M | $-184M | $-152M | $-153M | |
| Interest Expense | $4.0K | $9.0K | $12.0K | $215.0K | |
| Pretax Income | $-151M | $-164M | $-129M | $-147M | |
| Income Tax | $414.0K | $-598.0K | $6M | $896.0K | |
| Net Income | $-69M | $-61M | $-35M | · | |
| EPS (Basic) | · | · | · | $-0.23 | |
| EPS (Diluted) | · | · | · | $-0.23 | |
| Shares (Basic) | · | · | · | 61,540,231 | |
| Shares (Diluted) | · | · | · | 61,540,231 | |
| EBITDA | $-158M | $-178M | $-148M | · |
Balance Sheet
| Metric | Trend | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Cash & Equivalents | $109M | $99M | $61M | $490M | |
| Other Current Assets | $3M | $80.0K | $9.0K | $1M | |
| Current Assets | $281M | $396M | $374M | $505M | |
| PP&E (Net) | $51M | $42M | $42M | $11M | |
| Accum. Depreciation | $17M | $11M | $8M | $5M | |
| Intangibles | · | · | $0 | $213.0K | |
| Total Assets | $336M | $441M | $421M | $518M | |
| Accounts Payable | $940.0K | $4M | $5M | $3M | |
| Accrued Liabilities | $29M | $31M | $18M | $7M | |
| Current Liabilities | $31M | $36M | $25M | $11M | |
| Capital Leases | $3M | $2M | $4M | $2M | |
| Total Liabilities | $35M | $39M | $29M | $13M | |
| Paid-in Capital | $259M | $206M | $36M | $7M | |
| Retained Earnings | $-1.27B | $-1.20B | $-1.14B | $-1.10B | |
| AOCI | $56.0K | $130.0K | $130.0K | $0 | |
| Stockholders' Equity | $-1.01B | $-995M | $-1.10B | $-1.10B | |
| Liabilities + Equity | $336M | $441M | $421M | $518M |
Cash Flow
| Metric | Trend | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| D&A | $7M | $5M | $4M | $3M | |
| Stock-based Comp | $25M | $29M | $31M | $74M | |
| Amort. of Intangibles | $0 | $0 | $213.0K | $215.0K | |
| Other Non-cash | $-83M | $-100M | $-89M | · | |
| Operating Cash Flow | $-120M | $-126M | $-90M | $-77M | |
| CapEx | $15M | $30M | $34M | $2M | |
| Investing Cash Flow | $104M | $20M | $-330M | $-2M | |
| Stock Issued | $24M | $144M | $0 | $0 | |
| Stock Repurchased | $0 | $0 | $9M | $0 | |
| Net Stock Activity | $24M | $144M | $-9M | · | |
| Financing Cash Flow | $26M | $144M | $-10M | $549M | |
| Net Change in Cash | $9M | $38M | $-430M | $470M | |
| Taxes Paid | $2M | $73.0K | $3M | $2M | |
| Free Cash Flow | $-135M | $-156M | $-124M | · | |
| Levered FCF | $-135M | $-156M | $-124M | · |
Profitability
| Metric | Trend | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Operating Margin | -18477.8% | -241678.9% | · | · | |
| Net Margin | -7725.2% | -80507.9% | · | · | |
| Pretax Margin | -16931.5% | -215701.3% | · | · | |
| EBITDA Margin | -17741.5% | -234531.6% | · | · | |
| ROA | -17.8% | -14.2% | -7.6% | · | |
| ROE | 6.9% | 6.2% | 3.2% | · | |
| ROIC | 16.4% | 18.4% | 14.4% | · |
Liquidity & Solvency
| Metric | Trend | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Current Ratio | 9.1 | 10.9 | 14.9 | · | |
| Quick Ratio | 3.5 | 2.7 | 2.4 | · | |
| Interest Coverage | -41251.8 | -20408.4 | -12626.8 | · |
Efficiency
| Metric | Trend | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | · |
Per Share
| Metric | Trend | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| EPS (TTM) | · | · | · | $-0.23 |
Growth Rates
| Metric | Trend | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue YoY | 1075.0% | · | · | · |
Valuation (TTM)
| Metric | Trend | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue TTM | $893.0K | $76.0K | $0 | $0 | |
| Net Income TTM | $-69M | $-61M | $-35M | $-100M | |
| P/E | · | · | · | -29.8 | |
| Earnings Yield | · | · | · | -3.4% |
Income Statement
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $150.0K | $226.0K | $225.0K | $217.0K | $221.0K | $230.0K | $76.0K | $0 | $0 | $0 | |
| R&D Expense | $36M | $34M | $34M | $27M | $26M | $27M | $40M | $31M | $29M | $27M | |
| SG&A Expense | $12M | $11M | $11M | $12M | $14M | $14M | $12M | $18M | $14M | $13M | |
| Operating Expenses | $49M | $45M | $46M | $39M | $40M | $42M | $52M | $49M | $43M | $40M | |
| Operating Income | $-48M | $-45M | $-45M | $-39M | $-40M | $-41M | $-52M | $-49M | $-43M | $-40M | |
| Interest Expense | $1.0K | $15.0K | $1.0K | $2.0K | $1.0K | $0 | $2.0K | $2.0K | $3.0K | $2.0K | |
| Pretax Income | $-46M | $-43M | $-42M | $-35M | $-36M | $-37M | $-47M | $-43M | $-39M | $-35M | |
| Income Tax | $0 | $0 | $-2M | $560.0K | $848.0K | $591.0K | $2M | $-2M | $-56.0K | $98.0K | |
| Net Income | $-28M | $-20M | $-19M | $-16M | $-17M | $-17M | $-21M | $-18M | $-13M | $-9M | |
| EBITDA | $-48M | $-43M | · | $-39M | $-40M | $-40M | · | $-49M | $-43M | $-39M |
Balance Sheet
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $75M | $102M | $109M | $95M | $85M | $98M | $99M | $108M | $215M | $84M | |
| Other Current Assets | $772.0K | $2M | $3M | $110.0K | $546.0K | $62.0K | $80.0K | $1M | $0 | $0 | |
| Current Assets | $190M | $235M | $281M | $300M | $324M | $360M | $396M | $430M | $450M | $340M | |
| PP&E (Net) | $56M | $54M | $51M | $48M | $44M | $43M | $42M | $39M | $43M | $42M | |
| Accum. Depreciation | $19M | $18M | $17M | $15M | $14M | $12M | $11M | $11M | $9M | $8M | |
| Total Assets | $249M | $293M | $336M | $352M | $372M | $406M | $441M | $475M | $499M | $388M | |
| Accounts Payable | $2M | $3M | $940.0K | $2M | $2M | $3M | $4M | $3M | $3M | $3M | |
| Accrued Liabilities | $20M | $22M | $29M | $26M | $25M | $28M | $31M | $21M | $15M | $13M | |
| Current Liabilities | $23M | $26M | $31M | $29M | $28M | $33M | $36M | $25M | $21M | $19M | |
| Capital Leases | $2M | $3M | $3M | $3M | $3M | $2M | $2M | $5M | $6M | $5M | |
| Total Liabilities | $26M | $30M | $35M | $33M | $33M | $36M | $39M | $31M | $27M | $25M | |
| Paid-in Capital | $435M | $266M | $259M | $242M | $232M | $219M | $206M | $200M | $189M | $53M | |
| Retained Earnings | $-1.32B | $-1.29B | $-1.27B | $-1.25B | $-1.23B | $-1.22B | $-1.20B | $-1.18B | $-1.16B | $-1.15B | |
| AOCI | $-34.0K | $-53.0K | $56.0K | $74.0K | $30.0K | $75.0K | $130.0K | $321.0K | $-6.0K | $-44.0K | |
| Stockholders' Equity | $-884M | $-1.02B | $-1.01B | $-1.01B | $-1.00B | $-999M | $-995M | $-980M | $-972M | $-1.10B | |
| Liabilities + Equity | $249M | $293M | $336M | $352M | $372M | $406M | $441M | $475M | $499M | $388M |
Cash Flow
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $2M | $2M | $2M | $2M | $1M | $2M | $2M | $1M | $1M | $1M | |
| Stock-based Comp | $6M | $5M | $6M | $7M | $7M | $6M | $7M | $7M | $8M | $8M | |
| Other Non-cash | · | $-28M | · | · | · | $-21M | · | · | · | $-34M | |
| Operating Cash Flow | $-40M | $-42M | $-33M | $-27M | $-31M | $-30M | $-24M | $-29M | $-38M | $-35M | |
| CapEx | $4M | $4M | $6M | $5M | $3M | $1M | $26M | $2M | $636.0K | $960.0K | |
| Investing Cash Flow | $13M | $35M | $28M | $29M | $19M | $28M | $15M | $-82M | $29M | $58M | |
| Stock Issued | $0 | $7.0K | $17M | $7M | · | · | $-3.0K | $4M | · | · | |
| Net Stock Activity | · | $7.0K | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $541.0K | $215.0K | $18M | $8M | $-14.0K | $-12.0K | $123.0K | $4M | $140M | $-13.0K | |
| Net Change in Cash | $-27M | $-7M | $13M | $10M | $-13M | $-1M | $-9M | $-106M | $130M | $24M | |
| Free Cash Flow | · | $-45M | · | · | · | $-31M | · | · | · | $-36M | |
| Levered FCF | · | $-45M | · | · | · | $-31M | · | · | · | $-36M |
Profitability
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -32248.7% | -19881.9% | · | -17759.9% | -17967.9% | -17994.8% | · | · | · | · | |
| Net Margin | -18948.0% | -8865.9% | · | -7589.4% | -7489.6% | -7275.7% | · | · | · | · | |
| Pretax Margin | -30957.3% | -18858.9% | · | -16259.5% | -16342.5% | -16243.9% | · | · | · | · | |
| EBITDA Margin | -32248.7% | -19148.2% | · | -17759.9% | -17967.9% | -17299.1% | · | · | · | · | |
| ROA | -9.2% | -5.7% | · | -4.0% | -3.8% | -4.2% | · | -3.9% | -2.5% | -2.1% | |
| ROE | 3.0% | 2.0% | · | 1.7% | 1.7% | 1.6% | · | 1.7% | 1.1% | 0.70% | |
| ROIC | 5.5% | 4.4% | · | 3.9% | 4.0% | 4.2% | · | 4.7% | 4.4% | 3.7% |
Liquidity & Solvency
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 8.4 | 9.1 | · | 10.3 | 11.5 | 11.0 | · | 17.1 | 21.9 | 17.6 | |
| Quick Ratio | 3.3 | 3.9 | · | 3.3 | 3.0 | 3.0 | · | 4.3 | 10.4 | 4.4 | |
| Interest Coverage | -48373.0 | -2995.5 | · | -19269.5 | -39709.0 | · | · | -24486.5 | -14352.0 | -20038.0 |
Efficiency
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | · | · | · |
Valuation (TTM)
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $818.0K | $889.0K | · | $744.0K | $527.0K | $306.0K | · | · | · | · | |
| Net Income TTM | $-84M | $-72M | · | $-71M | $-72M | $-68M | · | $-46M | $-39M | $-35M |
Most recent period on the left · null values shown as ·
Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Revenue | $893.0K | $76.0K | $0 | $0 | · |
| Operating Margin % | -18477.8% | -241678.9% | · | · | · |
| Net Income | $-69M | $-61M | $-35M | · | $-55M |
| Diluted EPS | · | · | · | $-0.23 | · |
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Current Ratio | 9.1 | 10.9 | 14.9 | · | 0.5 |
| Quick Ratio | 3.5 | 2.7 | 2.4 | · | 0.2 |
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Free Cash Flow | $-135M | $-156M | $-124M | · | · |
Institutional owners (13F) 76 filers · $97.1M total · As of June 30, 2026
Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
Holders
76
Value held
$97.1M
New positions
24
Exited positions
21
Institutional activity — Q2 2026 vs prior quarter
| New positions | Exited positions | Increased | Decreased | Net shares change |
|---|---|---|---|---|
| 24 (+7 vs prior Q) | 21 (+16 vs prior Q) | 26 (+7 vs prior Q) | 11 (-12 vs prior Q) | +5.1M |
Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.
| Institution | Value | Shares | % of tracked 13F | Type |
|---|---|---|---|---|
| MONTANOVA CAPITAL, LLC | $25,176,183 | 12,341,266 | 25.92% | Shares |
| MORGAN STANLEY | $20,102,523 | 9,854,178 | 20.70% | Shares |
| BlackRock, Inc. | $10,602,343 | 5,197,227 | 10.92% | Shares |
| GEODE CAPITAL MANAGEMENT, LLC | $4,877,226 | 2,390,147 | 5.02% | Shares |
| Bleichroeder LP | $4,080,000 | 2,000,000 | 4.20% | Shares |
| VANGUARD GROUP INC | $3,692,033 | 1,648,229 | 3.80% | Shares |
| Artia Global Partners LP | $3,686,156 | 1,806,939 | 3.79% | Shares |
| VANGUARD CAPITAL MANAGEMENT LLC | $2,397,524 | 1,175,257 | 2.47% | Shares |
| RENAISSANCE TECHNOLOGIES LLC | $2,242,776 | 1,099,400 | 2.31% | Shares |
| MILLENNIUM MANAGEMENT LLC | $2,151,598 | 1,054,705 | 2.22% | Shares |
| STATE STREET CORP | $2,133,728 | 1,045,945 | 2.20% | Shares |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $1,594,727 | 781,729 | 1.64% | Shares |
| UBS Group AG | $1,369,752 | 671,447 | 1.41% | Shares |
| NORTHERN TRUST CORP | $1,356,247 | 664,827 | 1.40% | Shares |
| MYDA Advisors LLC | $1,307,181 | 640,775 | 1.35% | Shares |
| VANGUARD FIDUCIARY TRUST CO | $1,289,584 | 632,149 | 1.33% | Shares |
| BANK OF AMERICA CORP /DE/ | $1,112,122 | 545,158 | 1.14% | Shares |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $1,054,847 | 517,082 | 1.09% | Shares |
| Voleon Capital Management LP | $965,546 | 473,307 | 0.99% | Shares |
| Amundi | $620,468 | 304,151 | 0.64% | Shares |
| TWO SIGMA INVESTMENTS, LP | $557,448 | 273,259 | 0.57% | Shares |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $515,928 | 252,906 | 0.53% | Shares |
| GOLDMAN SACHS GROUP INC | $414,132 | 203,006 | 0.43% | Shares |
| Virtus Investment Advisers, LLC | $407,000 | 199,510 | 0.42% | Shares |
| Bank of New York Mellon Corp | $360,382 | 176,657 | 0.37% | Shares |
| Squarepoint Ops LLC | $227,997 | 111,763 | 0.23% | Shares |
| Nuveen, LLC | $206,980 | 101,461 | 0.21% | Shares |
| CITADEL ADVISORS LLC | $199,716 | 97,900 | 0.21% | Call option |
| Susquehanna Portfolio Strategies, LLC | $198,651 | 97,378 | 0.20% | Shares |
| FMR LLC | $171,780 | 84,206 | 0.18% | Shares |
| Abel Hall, LLC | $154,905 | 75,934 | 0.16% | Shares |
| DEUTSCHE BANK AG\ | $153,761 | 75,373 | 0.16% | Shares |
| WELLS FARGO & COMPANY/MN | $137,214 | 67,262 | 0.14% | Shares |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $127,500 | 62,500 | 0.13% | Call option |
| JANE STREET GROUP, LLC | $122,808 | 60,200 | 0.13% | Call option |
| RHUMBLINE ADVISERS | $110,361 | 54,101 | 0.11% | Shares |
| NEW YORK STATE COMMON RETIREMENT FUND | $93,024 | 45,600 | 0.10% | Shares |
| Invesco Ltd. | $83,067 | 40,719 | 0.09% | Shares |
| JANE STREET GROUP, LLC | $81,480 | 39,941 | 0.08% | Shares |
| AXQ CAPITAL, LP | $76,357 | 37,430 | 0.08% | Shares |
| JANE STREET GROUP, LLC | $74,256 | 36,400 | 0.08% | Put option |
| CITIGROUP INC | $72,188 | 35,386 | 0.07% | Shares |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | $71,078 | 34,842 | 0.07% | Shares |
| Vanguard Global Advisers, LLC | $69,511 | 34,074 | 0.07% | Shares |
| JPMORGAN CHASE & CO | $60,716 | 32,125 | 0.06% | Shares |
| CANADA PENSION PLAN INVESTMENT BOARD | $57,528 | 28,200 | 0.06% | Shares |
| Virtus Family Office LLC | $56,100 | 27,500 | 0.06% | Shares |
| Police & Firemen's Retirement System of New Jersey | $51,632 | 25,310 | 0.05% | Shares |
| ALLIANCEBERNSTEIN L.P. | $47,900 | 26,760 | 0.05% | Shares |
| R Squared Ltd | $36,357 | 17,822 | 0.04% | Shares |
Activists & 5%+ owners 5 positions
Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.
| Filer | Filed | Stake | Status | Purpose | Filing |
|---|---|---|---|---|---|
| Carlos Slim Helu, Carlos Slim Domit, Marco Antonio Slim Domit, Patrick Slim Domit, Maria Soumaya Slim Domit, Vanessa Paola Slim Domit, Johanna Monique Slim Domit, Control Empresarial de Capitales S.A. de C.V. | April 30, 2026 | 36.00% | Amendment | · | SEC |
| Tolerantia, LLC, Pablo Legorreta ×6 filings | June 5, 2025 | 36.50% | Amendment | · | SEC |
| Carlos Slim Helú, Carlos Slim Domit, Marco Antonio Slim Domit, Patrick Slim Domit, María Soumaya Slim Domit, Vanessa Paola Slim Domit, Johanna Monique Slim Domit, Control Empresarial de Capitales, S.A. de C.V. | June 25, 2024 | · | Initial filing | Passive investment | SEC |
| Chamath Palihapitiya, SC PIPE Holdings LLC, SC Master Holdings, LLC ×6 filings | Nov. 20, 2023 | · | Initial filing | · | SEC |
| Control Empresarial de Capitales, S.A. de C.V., Carlos Slim Helu, Carlos Slim Domit, Marco Antonio Slim Domit, Patrick Slim Domit, Maria Soumaya Slim Domit, Vanessa Paola Slim Domit, Johanna Monique Slim Domit | July 22, 2022 | · | Initial filing | Passive investment | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Company insiders 21 insiders · 10 officers · 10 directors
| Insider | Role | Last activity | Shares owned | Buys 12m | Sells 12m | Net 12m |
|---|---|---|---|---|---|---|
| Bruce Culleton | Chief Executive Officer | March 1, 2026 A | · | 0 | 0 | $0 |
| Timothy Bertram | Chief Executive Officer | Jan. 16, 2023 A | · | 0 | 0 | $0 |
| James Coulston | Chief Financial Officer | March 1, 2026 A | · | 0 | 0 | $0 |
| Deepak Jain | Chief Operating Officer | Jan. 16, 2023 A | · | 0 | 0 | $0 |
| Kenneth Thomas Locke | Chief Technical Officer | July 1, 2026 A | · | 0 | 0 | $0 |
| Todd C Girolamo | Chief Legal Officer | June 12, 2026 C | 327,713 | 0 | 0 | $0 |
| Darin J. Weber | Chief Regulatory Officer | March 1, 2026 A | 0 | 0 | 0 | $0 |
| Ulrich Peter Alfred Ernst | EVP, Technical Operations | April 1, 2024 A | · | 0 | 0 | $0 |
| Libbie Parker Mckenzie | Chief Medical Officer | Jan. 16, 2023 A | · | 0 | 0 | $0 |
| Mary Weger | Chief People Officer | Jan. 16, 2023 A | · | 0 | 0 | $0 |
| Brian Jg Pereira | Director | Aug. 20, 2026 S | 0 | 0 | 10 | $-2,951,047 |
| Santos Jose Ignacio Jimenez | Director | May 28, 2026 A | · | 0 | 0 | $0 |
| Jennifer A. Fox | Director | May 28, 2026 A | · | 0 | 0 | $0 |
| Uma Sinha | Director | May 28, 2026 A | 30,000 | 0 | 0 | $0 |
| Pablo Legorreta | Director | May 28, 2026 A | · | 0 | 0 | $0 |
| Alan Lotvin | Director | May 28, 2026 A | · | 0 | 0 | $0 |
| William F Doyle | Director | May 28, 2026 A | · | 0 | 0 | $0 |
| John Maraganore | Director | June 29, 2023 A | · | 0 | 0 | $0 |
| Control Empresarial de Capitales, S.A. de C.V. | 10% owner | April 28, 2026 C | 73,842,723 | 0 | 0 | $0 |
| Aaron Cowen | 10% owner | March 31, 2023 J | 4,050,675 | 0 | 0 | $0 |
| Chamath Palihapitiya | 10% owner | July 11, 2022 M | 16,273,000 | 0 | 0 | $0 |
Insiders from SEC Form 3/4/5 filings; net = open-market P/S only
ETF ownership Held by 11 ETFs
Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.
| Fund | Weight | Units | As of | Source |
|---|---|---|---|---|
| BBC · ETFis Series Trust I | 0.63% | 189,520 NS | July 31, 2026 | N-PORT |
| IWC · iShares Trust | 0.03% | 262,201 SH | Sept. 11, 2026 | Daily |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0.01% | 56,146 SH | Aug. 19, 2026 | Daily |
| IWO · iShares Trust | 0.01% | 488,056 SH | Sept. 11, 2026 | Daily |
| IWM · iShares Trust | 0.00% | 1,692,449 SH | Sept. 11, 2026 | Daily |
| RSSL · Global X Funds | 0.00% | 36,158 NS | July 31, 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0.00% | 1,175,257 SH | Aug. 19, 2026 | Daily |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0.00% | 431,983 SH | Aug. 19, 2026 | Daily |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0.00% | 20,498 SH | Aug. 19, 2026 | Daily |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0.00% | 8,455 SH | Aug. 19, 2026 | Daily |
| IWN · iShares Trust | · | 206,668 SH | Sept. 11, 2026 | Daily |
PROK Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside
rating · 15 analysts
BUY
Median target
$5.75
+234.3%
5 33.3%
Strong Buy
5 33.3%
Buy
4 26.7%
Hold
1 6.7%
Sell
0 0.0%
Strong Sell
12-Month Price Target
6 analysts · 2026-10-04Mean target $6.25 +263.4%
Now
Current price $1.72
Low$1.00
Mean$6.25
High$12.00
Peer comparison (GICS sub-industry) Key metrics vs sector peers
FY basis, prices as of each company's last fiscal year-end close.
| Ticker | Market Cap | P/E | Rev YoY | Net Margin | ROE | Gross Margin |
|---|---|---|---|---|---|---|
| PROK | · | · | 1075.0% | -7725.2% | 6.9% | · |
| PRME | $626M | -2.6 | 55.3% | -4342.4% | -221.4% | · |
| CBIO | $327M | -24.2 | -86.7% | -1419.6% | -90.0% | · |
| ALT | $400M | -3.6 | 105.0% | -214861.0% | -45.6% | · |
| ZURA | · | · | · | · | · | · |
| ALLO | $314M | -1.6 | -76.8% | · | -59.9% | · |
| MNPR | · | · | · | · | · | · |
| CAPR | $1.66B | -12.8 | -11.6% | · | -51.1% | · |
| NGNE | $319M | -4.9 | · | · | -33.6% | · |
| PBYI | $300M | 9.8 | -0.91% | 13.6% | 26.5% | · |
| RGNX | $733M | -3.8 | 104.5% | -113.8% | -122.5% | · |
Latest News Recent headlines mentioning this company
My Metrics Your personal watchlist — selected rows from Full Fundamentals
Pick the metrics that matter to you — click the + next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.
Source: SEC 10-Q filed Aug 10, 2026